According to literature data, mice with a genetic knockout of 210 kDa MLCK as well as wild-type mice treated with a small-molecule MLCK inhibitor are more resistant to lung injury in experimental models of sepsis due to the preservation of microvascular endothelial barrier function [16]. The gene discussed is MYLK; the disease is Sepsis.